This law seeks to ensure availability of medicines, active ingredients, biological products, and other goods necessary for public health
Specific objectives include:
- Promoting international cooperation for the development of the pharmaceutical industry.
- Ensuring access to and supply of pharmaceutical products and other necessary inputs.
- Strengthening the national pharmaceutical industry’s capabilities through specialized talent training and scientific research promotion.
- Stimulating pharmaceutical production through incentives and development credits.
- Encourage the proper use of medicines through educational and pharmacovigilance measures.
- Facilitating intersectoral coordination to strengthen good practices in pharmaceutical production.
- Promote the cooperation and inclusion of national specialists residing abroad.
- Promote tools and strategies for quality surveillance and control.
- Ensure continuous funding for research projects.
- Ensure national supply and the local value chain.
The Ministries of Science, Health and Commerce will have to include in their annual report to Congress a section on the progress of public policies resulting from this Law’s implementation during the first five years after its issuance.
